Press Release
FOR IMMEDIATE RELEASE Cambridge-based tech-bio company transforming drug discovery with explainable AI platform World-leading bio and AI team is developing methodology to accelerate high-confidence target discovery Cambridge, UK – January 14, 2026 – Acuity Technologies Ltd today announced that it is developing its transformative drug discovery platform with world-leading researchers at the University of Cambridge. This distinctive team is led in Biology by Professor David Rubinsztein,...
